U.S. markets close in 5 hours 43 minutes

Lawrence Bruno Is The COO, President & Supervisory Director of Core Laboratories N.V. (NYSE:CLB) And They Just Spent US$105k On Shares

Simply Wall St

Potential Core Laboratories N.V. (NYSE:CLB) shareholders may wish to note that the COO, President & Supervisory Director, Lawrence Bruno, recently bought US$105k worth of stock, paying US$34.86 for each share. That's a very solid buy in our book, and increased their holding by a noteworthy 38%.

See our latest analysis for Core Laboratories

The Last 12 Months Of Insider Transactions At Core Laboratories

Over the last year, we can see that the biggest insider purchase was by Supervisory Director Gregory Barnett for US$116k worth of shares, at about US$40.00 per share. So it's clear an insider wanted to buy, even at a higher price than the current share price (being US$36.97). While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. In our view, the price an insider pays for shares is very important. Generally speaking, it catches our eye when insiders have purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price.

Over the last year, we can see that insiders have bought 8.00k shares worth US$310k. But insiders sold 428 shares worth US$28k. Overall, Core Laboratories insiders were net buyers last year. You can see the insider transactions (by individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

NYSE:CLB Recent Insider Trading, February 6th 2020

Core Laboratories is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Insider Ownership

For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Insiders own 1.8% of Core Laboratories shares, worth about US$29m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

What Might The Insider Transactions At Core Laboratories Tell Us?

It is good to see the recent insider purchase. And an analysis of the transactions over the last year also gives us confidence. When combined with notable insider ownership, these factors suggest Core Laboratories insiders are well aligned, and that they may think the share price is too low. If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.